Phibro Animal Health Corp
NASDAQ:PAHC

Watchlist Manager
Phibro Animal Health Corp Logo
Phibro Animal Health Corp
NASDAQ:PAHC
Watchlist
Price: 39.87 USD 4.15%
Market Cap: 1.6B USD

Phibro Animal Health Corp
Additional Paid In Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Phibro Animal Health Corp
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Phibro Animal Health Corp
NASDAQ:PAHC
Additional Paid In Capital
$137.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Johnson & Johnson
NYSE:JNJ
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Additional Paid In Capital
$46.3B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
42%
Pfizer Inc
NYSE:PFE
Additional Paid In Capital
$94.2B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Additional Paid In Capital
$44.8B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Additional Paid In Capital
$7.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
No Stocks Found

Phibro Animal Health Corp
Glance View

Market Cap
1.6B USD
Industry
Pharmaceuticals

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 1,725 full-time employees. The company went IPO on 2014-04-11. The firm operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The firm develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The firm sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The firm's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

PAHC Intrinsic Value
38.16 USD
Overvaluation 4%
Intrinsic Value
Price

See Also

What is Phibro Animal Health Corp's Additional Paid In Capital?
Additional Paid In Capital
137.3m USD

Based on the financial report for Sep 30, 2025, Phibro Animal Health Corp's Additional Paid In Capital amounts to 137.3m USD.

What is Phibro Animal Health Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
2%

Over the last year, the Additional Paid In Capital growth was 1%.

Back to Top